Zonisamide improves axial symptoms in dementia with Lewy bodies with parkinsonism: Post hoc analysis of clinical trials()

Patients with dementia with Lewy bodies (DLB) experience worsening axial symptoms with disease progression, which can negatively affect quality of life. Previous phase 2 and 3 clinical trials conducted in Japan showed that zonisamide improved parkinsonism in patients with DLB. In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuboi, Yoshio, Kochi, Kenji, Maruyama, Hidenori, Matsumoto, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703232/
https://www.ncbi.nlm.nih.gov/pubmed/34988303
http://dx.doi.org/10.1016/j.ensci.2021.100384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703232/
https://www.ncbi.nlm.nih.gov/pubmed/34988303
http://dx.doi.org/10.1016/j.ensci.2021.100384

Ejemplares similares